首頁 > 市場調查報告書 > 基礎設施

水處理

市場調查報告書

商品編碼

1687541

海水淡化和緩衝交換市場規模、佔有率及成長分析（按產品、方法、應用、最終用途和地區）- 產業預測，2025 年至 2032 年

Desalting and Buffer Exchange Market Size, Share, and Growth Analysis, By Product (Cassettes & Cartridges, Membrane Filters), By Technique (Filtration, Chromatography), By Application, By End-Use, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月17日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年海水淡化和緩衝交換市場規模為 13.4 億美元，預計將從 2024 年的 14.7 億美元成長到 2032 年的 31.6 億美元，預測期內（2025-2032 年）的複合年成長率為 10.0%。

由於生物製藥研究和生產需求的不斷增加，全球海水淡化和緩衝液交換市場正在經歷顯著成長。推動這項擴張的關鍵因素包括人們對蛋白質精製技術的認知不斷提高以及生技藥品的採用日益增加。層析法和過濾方法的技術創新將進一步擴大市場機會。製藥和生物技術產業是這些技術的主要消費者，有助於加速市場發展。雖然北美和歐洲目前憑藉其成熟的研究基礎設施佔據主導地位，但亞太地區也具有顯著的成長潛力。海水淡化技術、可擴展性解決方案和緩衝液交換過程的永續性的持續進步，以及行業參與者之間的戰略夥伴關係關係，是塑造競爭格局的值得關注的趨勢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Thermo Fisher Scientific（USA）
Sartorius AG（Germany）
Merck KGaA（Germany）
Danaher Corporation（USA）
Agilent Technologies（USA）
Repligen Corporation（USA）
GE HealthCare Technologies（USA）
Bio-Works Technologies（Sweden）
Norgen Biotek Corp（Canada）
Bio-Rad Laboratories（USA）
Avantor, Inc.（USA）
Pall Corporation（USA）
Waters Corporation（USA）
EMD Millipore（USA）
Tosoh Bioscience（Japan）
PerkinElmer（USA）
Shimadzu Corporation（Japan）
Lonza Group（Switzerland）

結論和建議

簡介目錄

Product Code: SQMIG30B2031

Desalting and Buffer Exchange Market size was valued at USD 1.34 billion in 2023 and is poised to grow from USD 1.47 billion in 2024 to USD 3.16 billion by 2032, growing at a CAGR of 10.0% during the forecast period (2025-2032).

The global Desalting and Buffer Exchange market is experiencing significant growth, largely driven by the increasing demand in biopharmaceutical research and production. Key factors fueling this expansion include heightened awareness of protein purification techniques and the rising adoption of biologics. Technological innovations in chromatography and filtration methods further enhance market opportunities. The primary consumers of these technologies are the pharmaceutical and biotechnology sectors, which are instrumental in accelerating market development. North America and Europe currently dominate due to established research infrastructures, while the Asia-Pacific region presents substantial growth potential. Ongoing advancements in desalting technologies, scalability solutions, and sustainability in buffer exchange processes are noteworthy trends, alongside strategic partnerships among industry players shaping the competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Desalting And Buffer Exchange market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Desalting And Buffer Exchange Market Segments Analysis

Global Desalting and Buffer Exchange Market is segmented by Product, Technique, Application, End-Use and region. Based on Product, the market is segmented into Cassettes & Cartridges, Membrane Filters, Spin Columns, Filter Plates, Kits and Other Consumables. Based on Technique, the market is segmented into Filtration, Chromatography and Precipitation. Based on Application, the market is segmented into Bioprocess Applications, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Diagnostic Applications. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Desalting And Buffer Exchange Market

The growing demand for biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, serves as a significant catalyst for the desalting and buffer exchange market. As the biopharmaceutical sector experiences continuous growth, the necessity for efficient purification methods increases, with desalting and buffer exchange being pivotal in this process. These advanced purification techniques are becoming essential in meeting the rising requirements of the industry, ensuring the production of high-quality biopharmaceuticals. Consequently, the emphasis on developing effective and sustainable purification solutions will drive the market for desalting and buffer exchange, aligning with the broader trends within the biopharmaceutical landscape.

Restraints in the Desalting And Buffer Exchange Market

A significant restraint in the Desalting and Buffer Exchange market is the high initial costs associated with the adoption of advanced desalting and buffer exchange technologies. The capital-intensive requirements for acquiring and integrating these sophisticated systems can pose a challenge, particularly for smaller research labs or organizations with constrained financial resources. These elevated expenses may deter potential users from investing in essential equipment, thus limiting market growth and making it difficult for smaller entities to compete with larger counterparts that can more easily absorb these costs. Consequently, these financial barriers restrict broader access to advanced desalting solutions in the marketplace.

Market Trends of the Desalting And Buffer Exchange Market

The Desalting and Buffer Exchange market is currently experiencing significant growth driven by the rising adoption of automated and high-throughput technologies. These advancements enhance process efficiency, reduce manual labor, and minimize processing times, particularly crucial for large-scale biopharmaceutical manufacturing. Additionally, the industry is increasingly focusing on sustainable practices, with a notable shift towards the use of biodegradable materials in desalting and buffer exchange technologies. This trend aligns with the global push for environmental responsibility, reflecting a broader consciousness among biopharmaceutical companies to embrace eco-friendly solutions while improving operational efficiencies in their manufacturing processes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Desalting and Buffer Exchange Market Size by Product & CAGR (2025-2032)

Market Overview
Cassettes & Cartridges
Membrane Filters
Spin Columns
Filter Plates
Kits
Other Consumables

Global Desalting and Buffer Exchange Market Size by Technique & CAGR (2025-2032)

Market Overview
Filtration
Chromatography
Precipitation

Global Desalting and Buffer Exchange Market Size by Application & CAGR (2025-2032)

Market Overview
Bioprocess Applications
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Applications

Global Desalting and Buffer Exchange Market Size by End-Use & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Diagnostic Laboratories

Global Desalting and Buffer Exchange Market Size & CAGR (2025-2032)

North America (Product, Technique, Application, End-Use)
- US
- Canada
Europe (Product, Technique, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technique, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technique, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technique, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Repligen Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Works Technologies (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMD Millipore (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments